Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward

SIMPLE SUMMARY: This review summarizes the current evidence around neoadjuvant radiotherapy and systemic therapy for retroperitoneal sarcoma (RPS). While surgery is the cornerstone of treatment for these tumors, data from prospective studies, retrospective studies, early phase trials, and—most recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Istl, Alexandra C., Gronchi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998126/
https://www.ncbi.nlm.nih.gov/pubmed/35406603
http://dx.doi.org/10.3390/cancers14071831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998126/
https://www.ncbi.nlm.nih.gov/pubmed/35406603
http://dx.doi.org/10.3390/cancers14071831

Ejemplares similares